Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings

Author(s):
Collarino, A.; Koster, E.J. de; Olmos, R.A.V.; Geus-Oei, L.F. de; Arias-Bouda, L.M.P.
Published
2018
Publication type
Article / Letter to editor
Locally advanced BCNAC responseNuclear breast imagingTc-99m-sestamibiTherapy monitoring
Date issued
2018-02-28
Language
English
Is part of
Clinical Breast Cancer (2018), Vol. 18, no. 1, p. 9-18
hdl
1887/95881
doi
10.1016/j.clbc.2017.06.008